Compare ARK Genomic Revolution ETF (ARKG) vs Walt Disney Co (DIS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Walt Disney Co — how do they compare? ARK Genomic Revolution ETF trades at $41.24, while Walt Disney Co trades at $96.01 (market cap $166.05B). The key difference: Walt Disney Co pays a 1.57% dividend while ARK Genomic Revolution ETF pays none, and ARK Genomic Revolution ETF is trading nearer its 52-week high, Walt Disney Co nearer its low. Which is the better fit depends on your goals.
| ARKG | DIS | |
|---|---|---|
Sector | Sector/Thematic | Media |
52-Week High | $43.57 | $122.94 |
52-Week Low | $23.09 | $92.40 |
Market Cap | — | $166.05B |
Volume | — | 7,546,013 |
Enterprise Value | — | $207.72B |
Dividend Yield | — | 1.57% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
Disney (DIS) trades at $95.63, down 0.55% on the day, with technical indicators signaling a bearish trend amid neutral oscillators. The company shows strong fundamentals with revenue growth to $94.43B in 2025 and net income surging to $12.40B, supported by consistent earnings beats. Recent news highlights advertising opportunities with major events in 2027 but also notes box office challenges for new releases.
Outlook remains positive given analyst consensus price target of $131.89 and 61.9% buy ratings, though risks include regulatory disputes with the FCC and content performance volatility. The stock presents a valuation opportunity with a P/E of 15.3 below industry averages, but investors should monitor debt levels and competitive pressures.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Walt Disney Co
The Walt Disney Company is an entertainment company with operations in media networks, park experiences & consumer products, studio entertainment and Direct-to-Consumer networks and channels. The Company serves customers worldwide.
Read more on DIS →
